Tag: ASX:EMV
EMVision’s brain scanner moves to production with $1.25M gov’t grant
EMVision Medical Devices Limited has established its pilot commercial production line and received a $1.25 million non-dilutive cash payment under the Modern Manufacturing Initiative (MMI) grant program.
EMVision’s neuroimaging advancements fueled by $15.28M from Keysight Technologies
EMVision Medical Devices Limited announced a strategic AUD 15.28 million investment from Keysight Technologies Inc, to bolster the former's neuroimaging technology and its potential to revolutionise diagnosis and treatment outcomes for neurological disorders.
EMVision expands product suite with 2nd gen helmet scanner prototype
Australian medical device company EMVision Medical Devices Limited announced the successful assembly of an advanced 28-antenna prototype for its 2nd Gen ultra-lightweight helmet scanner.
EMVision activates stage two trial for portable brain scanner
ASX-listed EMVision Medical Devices (EMV) has moved forward to stage two of the multi-site trial for its first-generation portable brain scanner.
EMVision receives $600K milestone payment, shares clinical trial updates
Medical imaging technology company EMVision Medical Devices has secured a $600,000 payment after achieving an “important milestone” for its portable imaging devices. The payment comes from the Australian Stroke Alliance, as part of the Commonwealth of Australia Medical Research Future Fund (MRFF) program.
Featured Article
Building resilience as manufacturing requirements become more complex
The industrial machinery and heavy equipment manufacturing sector is critical not only for its direct outputs, machines, and equipment that pave the way for construction, agriculture and manufacturing but also for its crucial role in economic development and innovation.
